FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.

Quarter-by-quarter ownership
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$281,000
+8.1%
1,8000.0%0.00%
-25.0%
Q1 2020$260,000
-29.3%
1,8000.0%0.00%0.0%
Q4 2019$368,000
+0.8%
1,800
-72.4%
0.00%0.0%
Q4 2018$365,000
-6.4%
6,510
+36.6%
0.00%0.0%
Q3 2018$390,0004,7650.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders